2m 2m 2m 2m 2m 2m 2m
ARCUTIS BIOTHER (ARQT)
NASDAQ
$26.26-$0.40 (-1.50%)
Price as of Jun 23, 2026 5:39 PM EDT- $3.3BMarket Cap
- 85.14%1-Year Change
- BiotechnologyIndustry
ARCUTIS BIOTHER (ARQT)
$26.26-$0.40 (-1.50%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 376.1M +91.34% | 196.5M +229.74% | 59.6M +1,517.09% | 3.7M N/A | |
Cost of Revenue | 36.7M +91.84% | 19.1M +283.56% | 5.0M +561.41% | 754,000 N/A | |
Gross Profit | 339.4M +91.29% | 177.4M +224.82% | 54.6M +1,762.86% | 2.9M N/A | |
Sales and Marketing Expense | 274.6M +19.69% | 229.4M +23.90% | 185.1M N/A | N/A N/A | |
Research and Development Expense | -77.1M +0.83% | -76.4M -30.89% | -110.6M -39.39% | -182.4M +25.33% | |
Depreciation and Amortization Expense | 4.7M +138.23% | 2.0M +161.20% | 750,000 +140.38% | 312,000 -31.28% | |
Total Operating Expenses | 388.3M +19.50% | 324.9M +8.06% | 300.7M -1.51% | 305.3M +47.83% | |
Operating Profit | -12.2M -90.48% | -128.4M -46.75% | -241.1M -20.07% | -301.6M +46.05% | |
Interest Income | 8.9M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -12.1M -55.51% | -27.2M -8.45% | -29.7M +89.83% | -15.7M +11,080.00% | |
Interest Income and Expense and Net | -3.2M -88.22% | -27.2M -8.45% | -29.7M +89.83% | -15.7M +11,080.00% | |
Total Nonoperating Income and Expense | 443,000 -97.26% | 16.2M +37.22% | 11.8M +219.89% | -9.8M -5,782.66% | |
Income before Taxes | -15.0M -89.26% | -139.4M -46.19% | -259.0M -14.12% | -301.6M +46.05% | |
Income Taxes | 1.2M +80.99% | 647,000 -79.22% | 3.1M N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -16.1M -88.47% | -140.0M -46.58% | -262.1M -15.83% | -311.5M +50.93% | |
Net Income from Continuing Operations Applicable to Common | -16.1M -88.47% | -140.0M -46.58% | -262.1M -15.83% | -311.5M +50.93% | |
Basic EPS and Net Income | -0.13 -88.79% | -1.16 -69.31% | -3.78 -33.22% | -5.66 +35.41% | |
Diluted EPS and Net Income | -0.13 -88.79% | -1.16 -69.31% | -3.78 -33.22% | -5.66 +35.41% | |
Basic Weighted Average Shares | 127.2M +5.19% | 121.0M +74.53% | 69.3M +25.94% | 55.0M +11.39% | |
Diluted Weighted Average Shares | 127.2M +5.19% | 121.0M +74.53% | 69.3M +25.94% | 55.0M +11.39% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 42.9M -39.85% | 71.3M -19.30% | 88.4M +64.80% | 53.6M -44.38% | |
Short-Term Investments | 178.1M +13.70% | 156.6M -14.63% | 183.5M -48.46% | 355.9M +22.48% | |
Cash and Cash Equivalents and Short-Term Investments | 221.0M -3.06% | 228.0M -16.15% | 271.9M -33.63% | 409.6M +5.82% | |
Total Current Assets | 411.2M +22.46% | 335.8M +1.63% | 330.4M -24.46% | 437.4M +8.60% | |
Accumulated Depreciation | 3.2M +26.68% | 2.6M +33.26% | 1.9M +66.87% | 1.2M +116.73% | |
Property and Plant and Equipment and Net | 1.0M +0.19% | 1.0M -32.36% | 1.5M -18.18% | 1.9M -16.81% | |
Total Long-Term Assets | 1.4M +138.09% | 596,000 0.00% | 596,000 +664.10% | 78,000 0.00% | |
Total Assets | 433.0M +24.10% | 348.9M +2.20% | 341.4M -24.02% | 449.3M +10.08% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 129.8M +60.27% | 81.0M +73.59% | 46.7M +23.44% | 37.8M +13.45% | |
Total Long-Term Debt | 108.0M +0.71% | 107.2M -46.88% | 201.8M +2.04% | 197.8M +173.35% | |
Total Long-Term Liabilities | 431,000 -24.39% | 570,000 -32.86% | 849,000 N/A | 0 -100.00% | |
Total Liabilities | 243.5M +27.25% | 191.3M -24.28% | 252.7M +5.43% | 239.7M +116.97% | |
Retained Earnings | -1.1B +1.44% | -1.1B +14.26% | -981.9M +36.42% | -719.8M +76.28% | |
Total Stockholders Equity | 189.5M +20.27% | 157.5M +77.68% | 88.7M -57.69% | 209.6M -29.59% | |
Total Shares Outstanding | 123.3M +4.65% | 117.8M +21.76% | 96.8M +58.57% | 61.0M +21.45% | |
Cash Flow | |||||
Cash from Operating Activities | -5.6M -94.98% | -112.2M -54.60% | -247.1M -4.14% | -257.7M +47.58% | |
Capital Expenditures | 686,000 +379.72% | 143,000 -66.59% | 428,000 +28.53% | 333,000 -66.53% | |
Cash from Investing Activities | -30.3M -204.97% | 28.8M -84.01% | 180.2M +306.69% | -87.2M +14.81% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.0M -89.47% | 66.2M -34.66% | 101.3M -66.43% | 301.8M +7.04% | |
Financials Ratio | |||||
Gross Margin | 90.24% -0.03% | 90.27% -1.49% | 91.63% +15.20% | 79.54% N/A | |
Operating Margin | -3.25% -95.02% | -65.33% -83.85% | -404.49% -95.06% | -8,183.04% N/A | |
Return on Assets | -4.13% -89.82% | -40.58% -38.81% | -66.31% -8.72% | -72.65% +24.35% | |
Return on Equity | -9.30% -91.82% | -113.76% -35.29% | -175.79% +43.15% | -122.80% +69.09% | |
Revenue Growth | 91.34% -60.24% | 229.74% -84.86% | 1,517.09% N/A | N/A N/A | |
Current Ratio | 3.17 -23.59% | 4.15 -41.45% | 7.08 -38.80% | 11.57 -4.27% | |
Cash Ratio | 0.33 -62.46% | 0.88 -53.52% | 1.89 +33.51% | 1.42 -50.98% | |
Debt-to-Equity Ratio | 0.58 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.25 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow